BVT Discount Zert BIDU 27.09.2024/ DE000VM5URM4 /
11/06/2024 08:39:43 | Var.-0.42 | Denaro13:25:04 | Lettera13:25:04 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
83.28EUR | -0.50% | 83.52 Quantità in denaro: 900 |
83.88 Quantità in lettera: 900 |
Baidu Inc | - USD | 27/09/2024 | Call |
GlobeNewswire
13:31
HUM Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Human...
GlobeNewswire
13:30
Sonder Holdings Inc. Announces Amendment to Financing Agreement and Provides Update on Portfolio Opt...
GlobeNewswire
13:30
Agrify Corporation Announces $500K Turnkey Extraction Equipment Deal with Grotech Farms LLC in Bridg...
GlobeNewswire
13:18
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Clas...
GlobeNewswire
13:15
AppTech Payments Announces Strategic Partnership with FISB Solutions to Upgrade Legacy Banking Syste...
GlobeNewswire
13:05
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
GlobeNewswire
13:05
Banks are making climate commitments, but are they actually making a difference?
GlobeNewswire
13:03
New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectiv...
GlobeNewswire
13:00
Lithium Ionic Completes Acquisition of Remaining 15% of Salinas Properties, Minas Gerais, Brazil
GlobeNewswire
13:00
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic A...
GlobeNewswire
13:00
Simply Good Foods to Report Third Quarter Fiscal Year 2024 Financial Results on Thursday, June 27, 2...
GlobeNewswire
13:00
Republic enhances tokenized asset accessibility with Zero Hash's fiat and USDC payment rails
GlobeNewswire
13:00
Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule ...